Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
International Journal of Toxicology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Geier, D. A.
Right arrow Articles by Geier, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geier, D. A.
Right arrow Articles by Geier, M. R.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Articles

Neurodevelopmental Disorders Following Thimerosal-Containing Childhood Immunizations: A Follow-Up Analysis

David A. Geier1
Mark R. Geier2

1 MedCon, Inc., Silver Spring, Maryland, USA
2 The Genetic Centers of America, Silver Spring, Maryland, USA

Correspondence: Address correspondence to Mark R. Geier, MD, PhD, 14 Redgate Center, Silver Spring, MD 20905, USA. E-mail:mgeier{at}comcast.net

The authors previously published the first epidemiological study from the United States associating thimerosal from childhood vaccines with neurodevelopmental disorders (NDs) based upon assessment of the Vaccine Adverse Event Reporting System (VAERS). A number of years have gone by since their previous analysis of the VAERS. The present study was undertaken to determine whether the previously observed effect between thimerosal-containing childhood vaccines and NDs are still apparent in the VAERS as children have had a chance to further mature and potentially be diagnosed with additional NDs. In the present study, a cohort of children receiving thimerosal-containing diphtheria-tetanus-acellular pertussis (DTaP) vaccines in comparison to a cohort of children receiving thimerosal-free DTaP vaccines administered from 1997 through 2000 based upon an assessment of adverse events reported to the VAERS were evaluated. It was determined that there were significantly increased odds ratios (ORs) for autism (OR = 1.8, p < .05), mental retardation (OR = 2.6, p < .002), speech disorder (OR = 2.1, p <.02), personality disorders (OR=2.6, p <.01), and thinking abnormality (OR=8.2, p <.01) adverse events reported to the VAERS following thimerosal-containing DTaP vaccines in comparison to thimerosal-free DTaP vaccines. Potential confounders and reporting biases were found to be minimal in this assessment of the VAERS. It was observed, even though the media has reported a potential association between autism and thimerosal exposure, that the other NDs analyzed in this assessment of the VAERS had significantly higher ORs than autism following thimerosal-containing DTaP vaccines in comparison to thimerosal-free DTaP vaccines. The present study provides additional epidemiological evidence supporting previous epidemiological, clinical and experimental evidence that administration of thimerosal-containing vaccines in the United States resulted in a significant number of children developing NDs.

Key Words: Autistic Spectrum Disorders • Ethylmercury • Merthiolate • Thiomersal • VAERS

International Journal of Toxicology, Vol. 23, No. 6, 369-376 (2004)
DOI: 10.1080/10915810490902038
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 PediatricsHome page
A. E. Tozzi, P. Bisiacchi, V. Tarantino, B. De Mei, L. D'Elia, F. Chiarotti, and S. Salmaso
Neuropsychological Performance 10 Years After Immunization in Infancy With Thimerosal-Containing Vaccines
Pediatrics, February 1, 2009; 123(2): 475 - 482.
[Abstract] [Full Text] [PDF]

Home page
 Emerg. Med. J.Home page
P N Johnson, L McGoodwin, and W Banner Jr
Utilisation of Crotalidae polyvalent immune fab (ovine) for Viperidae envenomations in children
Emerg. Med. J., December 1, 2008; 25(12): 793 - 798.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
A. Agrawal, P. Kaushal, S. Agrawal, S. Gollapudi, and S. Gupta
Thimerosal induces TH2 responses via influencing cytokine secretion by human dendritic cells
J. Leukoc. Biol., February 1, 2007; 81(2): 474 - 482.
[Abstract] [Full Text] [PDF]